| Intake surgeon | Intake research nurse | Informed consent | Surgery | Follow-up 2 weeks | Follow-up 4 weeks | Follow-up 8 weeks | Follow-up 12 weeks | Follow-up 26 weeks | Follow-up 52 weeks | Follow-up 104 weeks | Follow-up 156 weeks | Follow-up 208 weeks | Follow-up 260 weeks |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Visit | 1 | 2 | 3 | 4 | Â | Â | 5 | Â | 6 | 7 | 8 | Â | Â | 9 |
Inclusion/exclusion criteria | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Informed consent | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Treatment preference | X | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Expected recovery | X | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Demographics & diagnosis | X | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Basic physical examination | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Neurological examination | X | X | Â | Â | Â | Â | X | Â | Â | X | X | X | X | X |
Randomisation | Â | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Dynamic X-ray | X | Â | Â | Â | Â | Â | X | Â | Â | X | X | X | X | X |
MRI | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | X | Â | Â | X |
CT | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | X | Â | Â | X |
NDI | Â | X | Â | Â | X | X | X | X | X | X | X | X | X | X |
McGill | Â | X | Â | Â | X | X | X | X | X | X | X | X | X | X |
VAS arm and neck | Â | X | Â | Â | X | X | X | X | X | X | X | X | X | X |
SF-36 | Â | X | Â | Â | X | X | X | X | X | X | X | X | X | X |
HADS | Â | X | Â | Â | Â | Â | X | Â | X | X | X | X | X | X |
Karasek | Â | X | Â | Â | X | X | X | X | X | X | X | X | X | X |
Likert | Â | Â | Â | Â | X | X | X | X | X | X | X | X | X | X |
Macnab | Â | Â | Â | Â | Â | Â | X | Â | X | X | X | Â | Â | X |
EuroQol and VAS | Â | X | Â | Â | X | X | X | X | X | X | X | X | X | X |
Cost diaries | Â | Â | Â | Â | Â | Â | Â | X | X | X | X | X | X | X |
Complications | Â | Â | Â | X | Â | Â | X | Â | Â | X | X | X | X | X |
Re-operation | Â | Â | Â | Â | Â | Â | X | Â | Â | X | X | X | X | X |